BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25403901)

  • 1. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
    Smith LA; Douglas J; Braxton AA; Kramer K
    J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centres.
    Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
    BMC Med Genomics; 2019 Aug; 12(1):123. PubMed ID: 31429751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counselors' views and experiences with the clinical integration of genome sequencing.
    Machini K; Douglas J; Braxton A; Tsipis J; Kramer K
    J Genet Couns; 2014 Aug; 23(4):496-505. PubMed ID: 24671342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).
    Ploug T; Holm S
    PLoS One; 2017; 12(7):e0179935. PubMed ID: 28671958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing.
    Arora S; Haverfield E; Richard G; Haga SB; Mills R
    J Genet Couns; 2016 Apr; 25(2):337-43. PubMed ID: 26283062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term impact of receiving incidental findings on parents undergoing genome-wide sequencing.
    Cheung F; Birch P; Friedman JM; ; ; Elliott AM; Adam S
    J Genet Couns; 2022 Aug; 31(4):887-900. PubMed ID: 35128755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    May T
    J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opt-in for secondary findings as part of diagnostic whole-exome sequencing: Real-life experience from an international diagnostic laboratory.
    Brunfeldt M; Kaare M; Saarinen I; Koskenvuo J; Kääriäinen H
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2180. PubMed ID: 37025058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Researcher Characteristics with Views on Return of Incidental Findings from Genomic Research.
    Wynn J; Martinez J; Duong J; Zhang Y; Phelan J; Fyer A; Klitzman R; Appelbaum PS; Chung WK
    J Genet Couns; 2015 Oct; 24(5):833-41. PubMed ID: 25592144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Views of primary care providers regarding the return of genome sequencing incidental findings.
    Strong KA; Zusevics KL; Bick D; Veith R
    Clin Genet; 2014 Nov; 86(5):461-8. PubMed ID: 24673592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
    Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
    Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing.
    Yu JH; Harrell TM; Jamal SM; Tabor HK; Bamshad MJ
    Am J Hum Genet; 2014 Jul; 95(1):77-84. PubMed ID: 24975944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choices of incidental findings of individuals undergoing genome wide sequencing, a single center's experience.
    Bishop CL; Strong KA; Dimmock DP
    Clin Genet; 2017 Jan; 91(1):137-140. PubMed ID: 27392285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
    Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of amended variant classification laboratory reports by genetic counselors in the United States and Canada: An exploratory study.
    Richardson B; Fitzgerald-Butt SM; Spoonamore KG; Wetherill L; Helm BM; Breman AM
    J Genet Couns; 2022 Apr; 31(2):479-488. PubMed ID: 34570930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental findings and future testing methodologies: potential application of the ACMG 2013 recommendations.
    Richardson A
    J Law Biosci; 2014 Sep; 1(3):378-387. PubMed ID: 27774177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.